Antimictobials Flashcards
1
Q
Colistin
A
Polymyxin E
- Targets cell membrane
- Active against gram - and non growing
- low resistance
- high toxicity
- limited to topicals
- resistance due to an enzyme that modifies lipid A
2
Q
Daptomycin (cubicin)
A
- Targets cytoplasmic membrane resulting in depolarization
- bactericidal
- active only against gram + (MRSA, VRSA, and VRE)
- resistance due to accumulation of mutations in different genes rather than a single mutation
3
Q
Beta lactams
A
- largest class of cell wall inhibitors
- only active against growing cells
- penicillins
- cephalosporins
- carbapenems
- monobactams
4
Q
Anti pseudomonals
A
- Ticarcillin and clavulanate/beta lactam and beta lactamase inhibitor
- Piperacillin and tazobactam
5
Q
Ampicillin
A
- Aminopenicillin
- increased activity against gram -
6
Q
Amoxicillin
A
Aminopenicillin
- increased activity against gram -
- greater oral bioavailability
7
Q
Methicillin
A
- semi synthetic
- decreased susceptibility to beta lactamase
- acid sensitive/can’t be given orally
- never used
8
Q
Nafcillin
A
- semi synthetic
- beta lactamase resistance
- give Naf for Staph
- acid stable; absorbed from GI
9
Q
Oxacillin
A
- semi synthetic
- beta lactamase resistance
- acid stable
10
Q
MRSA resistance
A
- acquisition of unique gene (mecA) encoding a unique PBP (PBP2A
- confers resistance to all bets lactam antibiotics
11
Q
1st generation cephalosporins
A
- narrow spectrum
- mostly gram positive with a few gram negatives
- cephalexin, cefazolin, cephalothin, cefadroxil
12
Q
2nd generation cephalosporins
A
- expanded spectrum
- better gram negative and some anaerobes
- cefoxitin, cefotetan, cefaclor, cefonicid
13
Q
3rd generation cephalosporins
A
- broad spectrum
- even better gram negative
- cefoperazone, ceftazidime, ceftriaxone, cefotaxime
14
Q
4th generation cephalosporins
A
- extended spectrum
- broad spectrum but not active against enterococci or anaerobes
- relatively resistant to beta lactamase
- cefepime
15
Q
5th generation cephalosporins
A
- active against MRSA, streptococcus, and several gram negatives including klebsiella
- ceftaroline
- prodrug that gets metabolized to active form
16
Q
Carbapenems
A
- imipenem
- meropenem
- widely used and broadest spectrum of beta lactams
- not active against MRSA and VRE
- resistance due to production of carbapenamase, efflux pumps, and porin change/loss
17
Q
Monobactams
A
- very narrow spectrum; active only against gram negative aerobes
- aztreonam
18
Q
Carbapenem resistance
A
- production of carbapenamase
- resistance in gram negative: klebsiella, acinetobactor, and pseudomonas
19
Q
Glycopeptides
A
- bind rapidly and irreversibly to the D-alanyl-D-alanine terminus
- inhibits transport across cell membrane and cross linking or parallel peptidoglycan chains
- vancomycin, bacitracin, teicoplanin
- gram negative resistance because too large to pass through outer membrane
20
Q
Vancomycin resistance
A
- substitution of terminal D-alanine with D-lactate and won’t bind vancomycin
21
Q
New drugs to treat VRSA
A
- daptomycin
- linezolid (zyvox)
- synercid
22
Q
Lipoglycopeptides
A
- newer derivatives of glycopeptides that have a tail that anchors them in the cell membrane
- telavancin, dalbavancin, and oritavancin
23
Q
Bacitracin
A
- cell wall inhibitor (inhibits translocation of peptidoglycan precursors)
- relatively toxic (restricted to topicals)
- most active against gram positive
- often combined with polymyxin and an aminoglycoside (neomycin)
24
Q
Fosfomycin
A
- cell wall inhibitor (inhibits formation of cytoplasmic subunits)
- used for single dose treatment of UTIs
25
Q
Cycloserine
A
- cell wall inhibitor (inhibits translocation and cross linking)
- anti TB, but NOT first choice
26
Q
Rifampin
A
- inhibits DNA dependent RNA polymerase
27
Q
Antimicrobials that target 30s subunit
A
Tetracyclines and amnioglycosides